In light of recent concerns surrounding potential rare side effects of the AstraZeneca-Oxford COVID-19 vaccine, the pharmaceutical giant has reiterated its commitment to patient safety while......
The government on Monday placed a purchase order with Serum Institute of India for 1.1 crore doses of Oxford COVID-19 vaccine, Covishield, each costing Rs 210, including the GST, and committed to......
In the wake of pharmaceutical giant AstraZeneca admitting in a UK court that its COVID vaccine can cause blood clots in rare cases, a group of doctors on Thursday expressed deep concern over the......
United Kingdom-based pharmaceutical major AstraZeneca has started global withdrawal of its COVID-19 vaccine, which was provided in India as 'Covishield' in partnership with Serum Institute of......
United Kingdom-headquartered pharmaceutical giant AstraZeneca (AZ) has admitted that in 'very rare cases' its Covid vaccine can cause a blood clot related side effect but the causal link is......
Stocks of Oxford COVID-19 vaccine, Covishield, are likely to start moving out of Serum Institute of India's facility here on early Tuesday morning, days ahead of the nationwide inoculation drive,......